Vitroscope
Vitroscope provides a platform for researchers to culture and perfuse living human tissue and organoids for drug and disease studies.
Vitroscope is a biotech & life sciences company. It has raised $7 million in disclosed funding. Its latest round was a Seed of $7 million in November 2026.
Overview
Vitroscope offers a hardware‑software platform that enables ex vivo culture of living human tissue slices, organoids and 3D bioprints under controlled physiological flow and gas conditions [0]. The system integrates closed‑loop perfusion, real‑time supernatant monitoring and a browser‑based interface for protocol design, imaging and data capture, requiring minimal training and fitting standard well‑plate formats. Researchers can maintain tissue viability for days, observe immune activity and assess drug effects in a native microenvironment, supporting applications such as disease modeling, blood‑brain‑barrier studies and multi‑organ interaction experiments. The company’s customers are academic laboratories and biotech firms conducting preclinical research, and its platform is cited as being used by leading research institutions [0]. Vitroscope has raised $7 million in seed funding. Employee numbers have not been disclosed.
Funding
Total disclosed: $7M across 1 round. Computed only from sourced rounds.
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| $7M | Seed | Cerberus Ventures, YZR Capital | Arcas VC +3 | Biotech & Life Sciences | 1 |
Investors
Questions and answers
What does Vitroscope do?
Vitroscope provides a platform for researchers to culture and perfuse living human tissue and organoids for drug and disease studies.
How much has Vitroscope raised?
Vitroscope has raised $7 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Vitroscope?
Investors in Vitroscope include Cerberus Ventures, YZR Capital, Arcas VC, Golden Egg Check, Devico Invest and 1 more.
Sources
- 1.Vitroscope raises $7M to turn living human tissue into a new source of drug discovery data — Tech.eu, Nov 3, 2026
- 2.Vitroscope · Official
- 3.Vitroscope · Official